INFECTION, HUMAN IMMUNODEFICIENCY VIRUS
Clinical trials for INFECTION, HUMAN IMMUNODEFICIENCY VIRUS explained in plain language.
Never miss a new study
Get alerted when new INFECTION, HUMAN IMMUNODEFICIENCY VIRUS trials appear
Sign up with your email to follow new studies for INFECTION, HUMAN IMMUNODEFICIENCY VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New HIV drug candidate targets resistant strains
Disease control OngoingThis study tests a new drug called ACC017 in adults with HIV that has become resistant to standard treatments. The trial aims to see if ACC017 can lower the amount of virus in the blood to undetectable levels. Participants receive either ACC017 or a placebo for two weeks, followe…
Matched conditions: INFECTION, HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
HIV patients may ditch daily pills for monthly shots in landmark trial
Disease control OngoingThis Phase 3 trial tests whether switching from daily HIV pills to monthly injections of cabotegravir and rilpivirine can keep the virus suppressed in adults with HIV. About 618 participants who are already virally suppressed will either stay on their current pills or switch to t…
Matched conditions: INFECTION, HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC